CSL Stock And 2 Australian Dividend Shares Backed By Earnings

Simply Wall St.

15 hours ago

With inflation, interest rate questions and energy prices all pulling markets in different directions, many investors are looking for income that feels steadier than short term sentiment. Dividend ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2656396122"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2656396122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2656396122?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","is_english":true,"pubTime":"2026-08-01 00:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2656396122","market":"hk","top_or_hot":-1,"title":"CSL Stock And 2 Australian Dividend Shares Backed By Earnings","media":"Simply Wall St.","content":"<div>\n<p>With inflation, interest rate questions and energy prices all pulling markets in different directions, many investors are looking for income that feels steadier than short term sentiment. Dividend ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-backed-by-earning\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CSL Stock And 2 Australian Dividend Shares Backed By Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCSL Stock And 2 Australian Dividend Shares Backed By Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-01 00:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-backed-by-earning><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With inflation, interest rate questions and energy prices all pulling markets in different directions, many investors are looking for income that feels steadier than short term sentiment. Dividend ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-backed-by-earning\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSL","symbol_name":"卡莱尔伙伴","start_time":0,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-backed-by-earning","article_id":"2656396122","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-backed-by-earning","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2656396122","pubTimestamp":1785514612,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"With inflation, interest rate questions and energy prices all pulling markets in different directions, many investors are looking for income that feels steadier than short term sentiment. Dividend Powerhouses, sometimes called Dividend Aristocrats, focus on companies with yields above 5% that are covered by earnings, growing and relatively stable. That combination can appeal if you want your portfolio to be paid while you wait for clearer signals from central banks and growth data. This...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CSL":"卡莱尔伙伴","XJO.AU":"标普/澳交所 200指数","XKO.AU":"标普/澳交所 300指数","CSL.AU":"CSL LIMITED","XAO.AU":"标普/澳交所 普通股指数"},"translate_title":"CSL 股票和 2 只澳大利亚股息股票得到盈利支持","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL":1.5,"XJO.AU":1.5,"XAO.AU":1.5,"CSL.AU":1.5,"XKO.AU":1.5},"content_text":"With inflation, interest rate questions and energy prices all pulling markets in different directions, many investors are looking for income that feels steadier than short term sentiment. Dividend Powerhouses, sometimes called Dividend Aristocrats, focus on companies with yields above 5% that are covered by earnings, growing and relatively stable. That combination can appeal if you want your portfolio to be paid while you wait for clearer signals from central banks and growth data. This article highlights 3 stocks from the Dividend Powerhouses screener that stand out on yield quality and consistency within this income focused universe. AdvertisementCSL (ASX:CSL) Overview: CSL is a global biopharmaceutical group that collects human plasma and develops specialised medicines, vaccines and therapies for conditions such as immune deficiencies, bleeding disorders, iron deficiency and kidney disease. It sells into healthcare systems worldwide from its bases in Australia, the United States and Europe. Operations: CSL generates about US$10.9b from CSL Behring, US$2.4b from CSL Vifor and US$2.2b from CSL Seqirus. The United States is its largest market at US$7.3b, with a broad Rest of World contribution of US$4.6b. Market Cap: A$61.3b CSL sits in the Dividend Powerhouses screener as an income stock with a twist, combining a 3.38% yield with a global plasma and vaccine business that many patients rely on. Recent results have been messy, with net profit margin at 9.1%, a large one off loss of US$2.1b and high debt levels that put more focus on execution. At the same time, earnings are forecast to grow strongly over the next few years, management is reshaping the cost base and the company is actively buying back shares. If you want to understand what that mix of short term pressure and long term potential really means for income focused investors, CSL deserves a closer look. CSL’s earnings story is being reshaped in real time, with cost work, a 3.38% yield and buybacks all pulling in the same direction. Get the fuller picture through the 2 key rewards and 4 important warning signs ASX:CSL Earnings & Revenue Growth as at Jul 2026 Northern Star Resources (ASX:NST) Overview: Northern Star Resources is a gold producer that explores, develops, mines and processes gold deposits across Western Australia, the Northern Territory and Alaska, then sells refined gold into global markets. Operations: Northern Star Resources generates A$1.9b from KCGM, A$1.2b from Pogo, A$1.1b from Jundee, A$1.0b from Carosue Dam, A$1.0b from Thunderbox & Bronzewing, and A$736.5m from Kalgoorlie. Market Cap: A$28.5b Northern Star Resources combines a 3.02% dividend yield with a portfolio of large, long life gold assets such as KCGM and the Hemi project. This provides direct exposure to global gold demand and a 10 year reserve backed production profile. Reported earnings growth has outpaced both the Australian market and the broader metals and mining sector, with profit margins at 22.2%. At the same time, free cash flow coverage of the dividend is thin and the balance sheet is fully funded by external borrowing, so execution on large projects such as the Fimiston mill expansion is important to monitor. With activist investor Elliott pushing for board and strategy changes in 2026, the next phase for Northern Star Resources may be particularly significant for income focused holders. Northern Star Resources looks like a growth story hiding inside an income stock, with its 3.02% yield, long life assets and major projects poised to reshape the profile for years. Before assuming the next chapter is straightforward, it is worth reading the 2 key rewards and 1 important warning sign ASX:NST Earnings & Revenue Growth as at Jul 2026 Evolution Mining (ASX:EVN) Overview: Evolution Mining is a gold producer that explores, develops and operates mines in Australia and Canada, selling gold and gold copper concentrates, with additional exposure to copper and silver resources. Operations: Evolution Mining generates about A$1.7b from Cowal, A$1.1b from Ernest Henry, A$780m from Mungari, A$680m from Red Lake, A$580m from Northparkes, A$156m from Corporate activities and A$153m from Mt Rawdon. Market Cap: A$22.5b Evolution Mining brings together high margin gold production, growing copper exposure and a focus on ESG that many institutional investors pay close attention to. Earnings growth has been strong in recent years, with net profit margins at 26% and return on equity above 23%, yet the current P/E is slightly below the peer average. At the same time, funding relies on external borrowing and the dividend record is uneven, which matters if you want reliable income from the Dividend Powerhouses screener. Add in the planned Carnaby Resources acquisition and the lithium joint venture, and you get a more complex earnings mix that could support resilience, but also raises questions about future cash flow and valuation that are worth unpacking in detail. Evolution Mining’s high margins, copper upside and below peer P/E raise a clear question about what the market is missing. Get the full story in the analysis report for Evolution Mining ASX:EVN P/E Ratio as at Jul 2026 The three Dividend Powerhouses in this article are only a starting point. The full Dividend Powerhouses (3%+ Yield) screener surfaces 28 more companies with income profiles and business stories that could be just as compelling. Use Simply Wall St to identify and analyze the specific catalysts, dividend coverage and earnings narratives that matter most to you, so you can focus on the highest conviction ideas in this 3%+ yield universe. Take Control of Your Investment Journey  If CSL or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen.\n            Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.\n            Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.\n            By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.\n         Seeking Alternatives Before Everyone Else? Fresh opportunities move fast. Some stocks are building quiet breakout momentum while they are still under the radar for now. Scan these ideas before the crowd and evaluate them carefully.  Spot emerging growth stories early by tracking hand picked 11 high quality undiscovered gems that pair solid fundamentals with business models the wider market has not fully caught yet. Position your portfolio for potential infrastructure upgrade trends by reviewing curated 35 power grid technology and infrastructure stocks that could be relevant as spending momentum builds across transmission and grid technology. Target future facing industries by screening 26 quantum computing stocks that sit at the intersection of advanced computing, research partnerships and real world commercial applications.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}